Tamoxifen for Progressive Transitional Cell Carcinoma Following Previous Chemotherapy Treatment

NCT00710970 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Urinary Bladder Neoplasms

Interventions

DRUG: Tamoxifen

Sponsor

Seth Lerner

Collaborators

[object Object]
[object Object]